FP
CMRX

Fiduciary Planning’s Chimerix, Inc. CMRX Stock Holding History

Fiduciary Planning’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-225
Closed -$6K – 282
2021
Q1 		$6K Hold
225
– – 0.01% 192
2020
Q4 		$6K Hold
225
– – 0.01% 174
2020
Q3 		$8K Buy
+225
New +$665 0.01% 122

Other funds holding CMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fiduciary Planning's CMRX Position: Q2 2021 in Review

Fiduciary Planning sold out of Chimerix, Inc. (CMRX) in Q2 2021, closing a stake of 225 shares — an estimated $6K sold.

Fiduciary Planning first reported a position in CMRX in Q3 2020 and held it in 3 quarters. The position peaked at $8K in Q3 2020. 109 funds tracked by Wall St. Rank hold CMRX as of Q2 2021.

  • Fiduciary Planning reported no remaining Chimerix, Inc. position as of Q2 2021 after selling out during the quarter.
  • Fiduciary Planning sold 225 Chimerix, Inc. shares in Q2 2021, an estimated $6K.
  • Fiduciary Planning first reported a position in Chimerix, Inc. in Q3 2020 and held it in 3 quarters.
  • Fiduciary Planning's Chimerix, Inc. position peaked at $8K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2021.

Based on Fiduciary Planning's 13F filing for Q2 2021, filed 6 Aug 2021.